ЛЕЧЕНИЕ ПАЦИЕНТОВ С РЕВМАТОИДНЫМ АРТРИТОМ ПРИ СОЧЕТАННОЙ ПАТОЛОГИИ
Аннотация
Сочетанная патология у пациентов с ревматоидным артритом. Выявление взаимосвязи с эффектом от медикаментозной терапии.
Ключевые слова
Полный текст:
![PDF PDF](http://journal-s.org/templates/article/pdf.png)
Литература
Vertkin A.L., Rumyantsev M.A., Skotnikov A.S. et al. Vestnik semeynoy meditsiny. 2011;(3):40–7.
Gasparyan A.A., Men’shikova I.V., Kanevskaya M.Z. Klinicheskaya meditsina. 2016; 94(10), рр. 745–753.
Gordeev A.V., Galushko E.A., Nasonov E.L. Nauchno-prakticheskaya revmatologiya. 2014;52(4):362–5.
Nasonov E.L., Karateev D.E., Chichasova N.V. Nauchno-prakticheskaya revmatologiya. 2013;51 (6):609–22
Nasonov E.L. Revmatologiya: klinicheskie rekomendatsii [Rheumatology: clinical recommendations]. Moskva: GEOTARMedia; 2010. 752 p.
Nikitina N.M., Afanas’ev I.A., Romanova T.A., Rebrov A.P. Sovremennaya revmatologiya. №1’15. P. 39-43.
Panafidina T.A., Kondrat’eva L.V., Gerasimova E.V. et al. Nauchno-prakticheskaya revmatologiya. 2014;52(3):283–289.
Popkova T.V., Novikova D.S., Nasonov E.L. Consilium medicum. 2008;10(11):128–35.
Starodubtseva I.A., Vasil’eva L.V. Meditsinskiy sovet, №5, 2016. P. 120-123
Boers M, Dijkmans B, Gabriel S, et al. Making an impact on mortality in rheumatoid arthritis. Targeting cardiovascular comorbidity. Arthritis Rheum. 2004;50:1734–9. doi: http://dx.doi.org/10.1002/art.20306
Charlson ME. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373–83. doi: 10.1016/0021-9681(87)90171-8
Franklin J, Lunt M, Bunn D, et al. Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis. 2007;66:308–312. doi: 10.1136/ard.2006.057265
Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11(3):229. doi 10.1186/ar2669
Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48:54–8. doi: 10.1002/art.10705
Jurgens MS, Jacobs JW, Bijlsma JW. The use of conventional diseasemodifying anti-rheumatic drugs in established RA. Best Pract Res Clin Rheumatol. 2011;25(4):523–33. doi:10.1016/j.berh.2011.10.006
Kadam UT, Jordan K, Croft PR. Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis. 2004;63:408–10. doi: 10.1136/ard.2003.007526
Kitas GD, Erb N. Tackling ischemic heart disease in rheumatoid arthritis. Rheumatology. 2003;42:607–13. doi: 10.1093/rheumatology/ keg175
Levy L, Fautrel B, Barnetche T, Schaeverbeke T. Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol. 2008;26:673–9.
Maradit-Kremers H, Nicola PJ, Crowsoon CS, et al. Cardiovascular death in rheumatoid arthritis. Arthritis Rheum. 2005;52:722–32. doi: 10.1002/art.20878
Osiri M, Sattayasomboon Y. Prevalence and out-patient medical costs of comorbid conditions in patients with rheumatoid arthritis. Joint Bone Spine. 2013;80(6):608–12. doi:10.1016/j.jbspin.2013.01.013
Pasceri V, Yeh ETH. A tale of two diseases. Atherosclerosis and rheumatoid arthritis. Circulation. 1999;100:2124–6. doi: 10.1161/01.CIR.100.21.2124
Sattar N, McCrey DW, Capell H, McInnes IB. Explaining how «high-grade» systemic inflammation accelerated vascular risk in rheumatoid arthritis. Circulation. 2003;108:2957–63. doi: 10.1161/01.CIR.0000099844.31524.05
Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid.arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631–7. doi: 10.1136/ard.2009.123919
Smolen JS, Landewe R, Breedveld FC, et al. EULAR recomendattions for the management of rheumatoid arthritis with syntethetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2014;73:492–509. doi: 10.1136/annrheumdis-2013-204573
DOI: https://doi.org/10.12731/2658-6649-2020-12-2-93-105
Ссылки
- На текущий момент ссылки отсутствуют.
(c) 2020 D. I. Khusainova, B. A. Bakirov, G. R. Zaripova, L. N. Khusainova, E. M. Aitova, I. L. Bayanova, I. L. Muzaeva, G. A. Khakamova
![Лицензия Creative Commons](http://licensebuttons.net/l/by-nc-nd/4.0/88x31.png)
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
ISSN 2658-6649 (print)
ISSN 2658-6657 (online)